Maxwell Biosciences
PrivateLast Round
VC Round
Aug 7, 2025
Total Funding Raised
$10.8M
Company Overview
Maxwell Biosciences is a biotechnology company developing a drug platform for synthetic, immune-inspired small molecules to combat a broad spectrum of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Defense Tech, Medical AI
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Maxwell Biosciences Comps
Public and private peers based on sector, stage, and business model.
Maxwell Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 7, 2025 | ||||
| Seed | Mar 10, 2022 | ||||
| Angel | Apr 6, 2021 |
Key People
Founding team and executive leadership
Maxwell Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | Seed |
| DecentraNet | Seed |
| Longevitytech.fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 7, 2025
$20M raised in a venture round.
- Mar 28, 2025
Developing a synthetic antimicrobial peptide LL-37.
Maxwell Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Maxwell Biosciences's valuation, stock price, and market status.
